In our observation, CBD recoveries usually begin with the signal Meta actually enforced. Generic policy citations rarely address the underlying issue. Appeals that answer that signal are more likely to clear. In many cases, the issue is a health-claim phrase, not the CBD ingredient itself.
Your CBD account is offline. You're not alone. Health-claim restrictions are now common for CBD advertisers. Across affected accounts, the same signals keep appearing. The language Meta accepts is often much narrower than its public guidance suggests.
Recovery starts with the signal Meta cited, not the broader policy category.
The sections below explain the pattern and what usually separates faster recoveries from slower ones.
Meta's ad standards prohibit health claims in ad copy and on landing pages. Meta's enforcement often flags language about medical outcomes or treatment (for example, “cure,” “treat,” or “prevent”). Holding a LegitScript certification or operator authorization does not exempt creative from Meta's health-claim review.
In our observation window, CBD suspensions rarely begin with the ingredient itself. They are more often triggered by the creative than by the ingredient. Phrases we have seen flagged include pain, anxiety, inflammation, sleep, medical, and treatment framing. Product framing (supplement vs. wellness item) does not change the read.
Ads Manager shows a generic Community Standards message. The Graph API shows the actual violation code. ComplyAi refers to this API-level policy data as the Enforcement Signal Layer. It is the structured policy data behind the generic Ads Manager message. In our observation, the strongest appeals address the specific violation code shown in the API. Relying only on the generic Ads Manager message is less effective.
Meta associates business assets through signals such as Business Manager relationships, Pages, and payment identities. Once an account is suspended, ComplyAi refers to this pattern as Asset Risk Propagation. A suspension on one account can raise scrutiny on nearby accounts across the same identity. Recovering the suspended account matters. Stopping the cascade matters more.
In our observation, CBD suspensions resolve in one of two ways. Suspensions that reverse are more likely to involve appeals that cite the specific violation code. They also tend to provide consistent evidence across the surfaces Meta reviews. Suspensions that stay unresolved continue into more appeal cycles. Some cascade to nearby accounts.
Ads Manager shows a generic policy citation. Meta's Ad Review Feedback surfaces the specific code cited. In our observation, appeals are more effective when they cite the specific violation code shown in Ad Review Feedback. Relying only on the generic policy category from Ads Manager is less effective.
In our observation, CBD suspensions rarely stay contained. Meta's review can extend beyond the restricted ad account to related Business Manager assets: linked ad accounts, Pages, and payment identities. Issues on related assets can affect the enforcement outcome if they stay unresolved.
In our observation, Meta's review window on a CBD suspension is short. Earlier appeals correlate with higher overturn rates. In our observation, well-anchored appeals clear at 30 to 35 percent on the first pass (ComplyAi Intelligence Graph, Q2 2026). Delayed resolution is often followed by broader enforcement across related assets.
ComplyAi identifies the specific violation code. We evaluate the connected business assets. We coordinate recovery across the enforcement surfaces in each CBD suspension.
In our observation, effective CBD appeals share three characteristics.
The violation. The specific violation code carries more detail than the generic Community Standards category shown in Ads Manager. The Graph API exposes the code behind the restriction. In our observation, appeals anchored to the specific code clear faster than appeals anchored to the general category.
The evidence. Appeals are stronger when they address the specific language that led to the restriction. Discussing the policy category in general is less effective.
The authorization. Operator authorization and licenses support compliance. They do not replace resolving the cited policy issue.
In our observation, appeals that address the cited health-claim code clear at 30 to 35 percent on the first pass (ComplyAi Intelligence Graph, Q2 2026).
Recovery timelines vary widely across CBD suspensions. In our observation, five patterns are commonly associated with slower recoveries.
Creative linked to an earlier restriction can still shape later reviews.
Why: The cited policy issue has not changed. Editing and resubmitting is less likely to resolve it than new creative that fully addresses the issue.
Generic policy statements rarely answer the specific issue Meta cited.
Why: Meta reviews the cited policy issue, not broad compliance claims.
Enforcement often extends across related business assets.
Why: Related accounts are reviewed together. A new ad account under the same Business Manager does not shield you. Existing enforcement issues often carry over.
Extra documents are not always helpful.
Why: In our observation, appeals work best when the evidence directly answers the cited issue. Extra documents tend to slow review.
In our observation, rapid repeat appeals often lead to slower recovery.
Why: Appeals that explain the fix tend to perform better than repeats.